Previous close | 42.57 |
Open | 42.90 |
Bid | 42.85 x 1800 |
Ask | 43.80 x 1200 |
Day's range | 42.75 - 43.51 |
52-week range | 33.33 - 43.84 |
Volume | |
Avg. volume | 3,445,390 |
Market cap | 88.39B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 15.88 |
EPS (TTM) | 2.73 |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | 1.47 (3.45%) |
Ex-dividend date | 16 May 2024 |
1y target est | 45.39 |
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?